Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SpineGuard is a commercial-stage French medical device company focused on making spine surgery safer through real-time, radiation-free guidance during bone implant placement. Its DSG® technology provides direct feedback to surgeons to prevent bone breaches and streamline implant placement, with demonstrated clinical benefits including reduced radiation exposure and improved procedural safety. The technology is also being integrated into surgical robotics. Over 100,000 surgical procedures have been secured worldwide with DSG®-enabled devices, supported by extensive clinical evidence and regulatory clearances in multiple regions[1][4][6].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SpineGuard.